Ebola Risk in Liberia?

Authorities report three cases of Ebola in Liberia, which was declared free of the virus in May.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, NASAJust two months ago, the World Health Organization (WHO) declared Liberia Ebola-free after more than a year of suffering from the ongoing outbreak in West Africa. But last week (June 28), a 17-year-old male died of an illness that had been managed as if it were malaria, and the following day a post-mortem swab test showed he had Ebola, according to a WHO statement. Such post-mortem testing is standard practice in the country, as Liberia—which remains at risk of importing the virus from the neighboring countries of Guinea and Sierra Leone—is under a 90-day period of vigilance that started in early May.

A follow-up inquiry found that the young man had been in contact with nearly 200 people while he was infected, two of which have tested positive for Ebola. These patients are now being treated and all 200 contacts are being closely monitored. Some households are under quarantine, and United Nations (UN) agencies such as UNICEF and the World Food Programme are providing food, bedding, and tents. The UN and nongovernmental organizations have also sent monitoring equipment to Liberia, and the WHO is sending experts in epidemiology and social mobilization in an effort to prevent further spread of the virus.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo